Navigation path

Pharmaceuticals - Community Register

  

Community list of not active orphan medicinal products


WITHDRAWN  

Product information

Myristoylated-peptidyl-recombinant SCR1-3 of human complement receptor type I

EU orphan designation number: EU/3/02/108
Active ingredient: Myristoylated-peptidyl-recombinant SCR1-3 of human complement receptor type I
Indication: Prevention of post transplantation graft dysfunction
Sponsor: Orexo AB
Virdings Allé 32 A, 754 50 Uppsala, Svërige

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
01/08/2002 Orphan designation EMEA/OD/013/02 (2002)3015 of 30/07/2002
29/06/2007 Change of name and/or address of sponsor EMEA/OD/016/02
30/09/2008 Transfer of orphan designation EMEA/OD/013/02/T/01 (2008)5596 of 26/09/2008
03/03/2009 Removal of orphan designation from Community Register